$LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Healthcare
Sector
Biotechnology
Industry
Roger A. Jeffs
CEO
170
Employees
$45.72
Current Price
$3.40B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $97,998.11 | 2,269 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 2 | $97,998.11 | 2,269 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 10 | 12 | $9,418,863.43 | 340,740 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 11 | 14 | $10,598,316.04 | 358,232 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 12 | 21 | $25,763,747.48 | 566,853 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Saggar Rajeev Chief Medical Officer | Sale | 29,534 | $76.84 | $2,269,380.75 | View Details |
155 more transactions available โ create a free account to see 12 months of history | ||||||
Showing 21โ21 of 21 transactions
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated$0.82
ActualN/A
Revenue
Estimated$201.54M
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.